Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP405651.RA8eRnQ4DjTm5DZMpTFZ1_RgsabVItdf1uBELAfdaInnE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP405651.RA8eRnQ4DjTm5DZMpTFZ1_RgsabVItdf1uBELAfdaInnE130_assertion type Assertion NP405651.RA8eRnQ4DjTm5DZMpTFZ1_RgsabVItdf1uBELAfdaInnE130_head.
- NP405651.RA8eRnQ4DjTm5DZMpTFZ1_RgsabVItdf1uBELAfdaInnE130_assertion description "[The anti-prostate cancer effects of pHyde in conjunction with chemotherapy agent were analyzed by in vitro and in vivo assays using adenoviral vector expressing pHyde (AdRSVpHyde) in combination with DNA damaging chemotherapeutic agent, cisplatin, and docetaxel, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP405651.RA8eRnQ4DjTm5DZMpTFZ1_RgsabVItdf1uBELAfdaInnE130_provenance.
- NP405651.RA8eRnQ4DjTm5DZMpTFZ1_RgsabVItdf1uBELAfdaInnE130_assertion evidence source_evidence_literature NP405651.RA8eRnQ4DjTm5DZMpTFZ1_RgsabVItdf1uBELAfdaInnE130_provenance.
- NP405651.RA8eRnQ4DjTm5DZMpTFZ1_RgsabVItdf1uBELAfdaInnE130_assertion SIO_000772 19016247 NP405651.RA8eRnQ4DjTm5DZMpTFZ1_RgsabVItdf1uBELAfdaInnE130_provenance.
- NP405651.RA8eRnQ4DjTm5DZMpTFZ1_RgsabVItdf1uBELAfdaInnE130_assertion wasDerivedFrom befree-20140225 NP405651.RA8eRnQ4DjTm5DZMpTFZ1_RgsabVItdf1uBELAfdaInnE130_provenance.
- NP405651.RA8eRnQ4DjTm5DZMpTFZ1_RgsabVItdf1uBELAfdaInnE130_assertion wasGeneratedBy ECO_0000203 NP405651.RA8eRnQ4DjTm5DZMpTFZ1_RgsabVItdf1uBELAfdaInnE130_provenance.